Bonesupport Holding AB
STO:BONEX

Watchlist Manager
Bonesupport Holding AB Logo
Bonesupport Holding AB
STO:BONEX
Watchlist
Price: 355.6 SEK 2.07%
Market Cap: 23.4B SEK
Have any thoughts about
Bonesupport Holding AB?
Write Note

P/OCF
Price to OCF

4 412.6
Current
-96.8
Median
23.4
Industry
Higher than median
Higher than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
4 412.6
=
Market Cap
23.7B SEK
/
Operating Cash Flow
5.4m SEK
All Countries
Close
Market Cap P/OCF
SE
Bonesupport Holding AB
STO:BONEX
23.7B SEK 4 412.6
FR
Pharnext SCA
OTC:PNEXF
6T USD -236 050.3
US
Abbvie Inc
NYSE:ABBV
300.2B USD 18.2
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 21.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD -135.5
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD 11.4
US
Epizyme Inc
F:EPE
94.1B EUR -476.6
AU
CSL Ltd
ASX:CSL
137.3B AUD 32.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD 20.7
US
Seagen Inc
F:SGT
39.3B EUR -76.9
NL
argenx SE
XBRU:ARGX
34.1B EUR -138.6

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More